New hope for Tough-to-Treat thymic cancer?
NCT ID NCT07324629
Summary
This study is testing an experimental drug called Sac-TMT for people with advanced thymic carcinoma, a rare cancer, whose disease has gotten worse after standard platinum-based chemotherapy. About 30 participants will receive the drug every two weeks to see if it shrinks their tumors and is safe. The main goal is to see how many people's tumors respond to this new treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THYMIC CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Shanghai Chest Hospital
Shanghai, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.